Die InFo ONKOLOGIE & HÄMATOLOGIE erscheint 6 Mal im Jahr mit einem Fokus auf den grossen Onkologie-Kongressen ASCO, AHA, ESMO, EHA und DGHO
InFo ONKOLOGIE & HÄMATOLOGIE
- 1 minute read

You May Also Like
- Cancer prevention
Constant dripping – alcohol and cancer
- "Patients W.A.I.T. Indicator"
Access to new drugs is becoming increasingly difficult
- Immunotherapy
Subcutaneously or intravenously?
- ASCO 2025
Supportive therapies for greater adherence and compliance
- Inoperable NSCLC
Efficacy of pembrolizumab in combination with concurrent chemoradiotherapy
- De-escalation strategies
De-escalation strategies – less is more
- Advanced NSCLC
MARIPOSA: Combination therapy as the new standard of care for EGFR-mutated NSCLC
- Precision therapy